These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 33771405)
1. Interactions of Spiritual Well-Being, Symptoms, and Quality of Life in Patients Undergoing Treatment for Non-Small Cell Lung Cancer: A Cross-Sectional Study. Lee MK Semin Oncol Nurs; 2021 Apr; 37(2):151139. PubMed ID: 33771405 [TBL] [Abstract][Full Text] [Related]
2. Quality of Life in NSCLC Survivors - A Multicenter Cross-Sectional Study. Hechtner M; Eichler M; Wehler B; Buhl R; Sebastian M; Stratmann J; Schmidberger H; Gohrbandt B; Peuser J; Kortsik C; Nestle U; Wiesemann S; Wirtz H; Wehler T; Bals R; Blettner M; Singer S J Thorac Oncol; 2019 Mar; 14(3):420-435. PubMed ID: 30508641 [TBL] [Abstract][Full Text] [Related]
3. Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer. Langendijk JA; Aaronson NK; de Jong JM; ten Velde GP; Muller MJ; Lamers RJ; Slotman BJ; Wouters EF J Clin Oncol; 2001 Apr; 19(8):2123-33. PubMed ID: 11304764 [TBL] [Abstract][Full Text] [Related]
4. Spiritual well-being and quality of life in Iranian women with breast cancer undergoing radiation therapy. Jafari N; Farajzadegan Z; Zamani A; Bahrami F; Emami H; Loghmani A Support Care Cancer; 2013 May; 21(5):1219-25. PubMed ID: 23138932 [TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in long-term survivors of unresectable locally advanced non-small cell lung cancer. Ran J; Wang J; Bi N; Jiang W; Zhou Z; Hui Z; Liang J; Feng Q; Wang L Radiat Oncol; 2017 Dec; 12(1):195. PubMed ID: 29197373 [TBL] [Abstract][Full Text] [Related]
6. Cross-Sectional Patient-Reported Outcome Measuring of Health-Related Quality of Life With Establishment of Cancer- and Treatment-Specific Functional and Symptom Scales in Patients With Penile Cancer. Draeger DL; Sievert KD; Hakenberg OW Clin Genitourin Cancer; 2018 Dec; 16(6):e1215-e1220. PubMed ID: 30201215 [TBL] [Abstract][Full Text] [Related]
7. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer. Brown J; Thorpe H; Napp V; Fairlamb DJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG; Stephens RJ; Waller D; West P; Peake MD J Clin Oncol; 2005 Oct; 23(30):7417-27. PubMed ID: 16157935 [TBL] [Abstract][Full Text] [Related]
8. Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Langendijk JA; ten Velde GP; Aaronson NK; de Jong JM; Muller MJ; Wouters EF Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):149-55. PubMed ID: 10758317 [TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in the randomized phase III trial of brigatinib vs crizotinib in advanced ALK inhibitor-naive ALK + non-small cell lung cancer (ALTA-1L). Garcia Campelo MR; Lin HM; Zhu Y; Pérol M; Jahanzeb M; Popat S; Zhang P; Camidge DR Lung Cancer; 2021 May; 155():68-77. PubMed ID: 33744781 [TBL] [Abstract][Full Text] [Related]
10. Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy. Ozturk A; Sarihan S; Ercan I; Karadag M Am J Clin Oncol; 2009 Feb; 32(1):65-72. PubMed ID: 19194128 [TBL] [Abstract][Full Text] [Related]
11. Derivation of utility values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 questionnaire values in lung cancer. Jang RW; Isogai PK; Mittmann N; Bradbury PA; Shepherd FA; Feld R; Leighl NB J Thorac Oncol; 2010 Dec; 5(12):1953-7. PubMed ID: 21155140 [TBL] [Abstract][Full Text] [Related]
12. Staged versus conventional nursing for patients receiving chemotherapy for advanced non-small cell lung cancer: a before and after study. Zhu L; Chen L; Kan H; Cai P Ann Palliat Med; 2021 Jan; 10(1):250-257. PubMed ID: 33474963 [TBL] [Abstract][Full Text] [Related]
13. Nutritional assessment and quality of life in patients with non-small cell lung cancer undergoing immunotherapy. Konstantinidis T; Fragkioudaki C; Patelarou E; Zografakis-Sfakianakis M; Naoum S; Tsatsou I; Kalemikerakis I; Govina O Int J Palliat Nurs; 2023 Mar; 29(3):118-128. PubMed ID: 36952358 [TBL] [Abstract][Full Text] [Related]
14. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Bergman B; Aaronson NK; Ahmedzai S; Kaasa S; Sullivan M Eur J Cancer; 1994; 30A(5):635-42. PubMed ID: 8080679 [TBL] [Abstract][Full Text] [Related]
15. Health related quality of life in locally advanced NSCLC treated with high dose radiotherapy and concurrent chemotherapy or cetuximab--pooled results from two prospective clinical trials. Hallqvist A; Bergman B; Nyman J Radiother Oncol; 2012 Jul; 104(1):39-44. PubMed ID: 22727262 [TBL] [Abstract][Full Text] [Related]
16. Effects of curative-intent lung cancer therapy on functional exercise capacity and patient-reported outcomes. Ha D; Ries AL; Lippman SM; Fuster MM Support Care Cancer; 2020 Oct; 28(10):4707-4720. PubMed ID: 31965306 [TBL] [Abstract][Full Text] [Related]
17. Associations between the spiritual well-being (EORTC QLQ-SWB32) and quality of life (EORTC QLQ-C30) of patients receiving palliative care for cancer in Cyprus. Kyranou M; Nicolaou M BMC Palliat Care; 2021 Aug; 20(1):133. PubMed ID: 34461881 [TBL] [Abstract][Full Text] [Related]
18. Symptom and quality of life benefit of afatinib in advanced non-small-cell lung cancer patients previously treated with erlotinib or gefitinib: results of a randomized phase IIb/III trial (LUX-Lung 1). Hirsh V; Cadranel J; Cong XJ; Fairclough D; Finnern HW; Lorence RM; Miller VA; Palmer M; Yang JC J Thorac Oncol; 2013 Feb; 8(2):229-37. PubMed ID: 23328549 [TBL] [Abstract][Full Text] [Related]
19. Effects of socioeconomic factors and cancer survivors' worries on their quality of life (QOL) in Japan. Kobayashi K; Morita S; Shimonagayoshi M; Kobayashi M; Fujiki Y; Uchida Y; Yamaguchi K Psychooncology; 2008 Jun; 17(6):606-11. PubMed ID: 17972358 [TBL] [Abstract][Full Text] [Related]
20. Quality of life during 5 years after stereotactic radiotherapy in stage I non-small cell lung cancer. Ubels RJ; Mokhles S; Andrinopoulou ER; Braat C; van der Voort van Zyp NC; Aluwini S; Aerts JG; Nuyttens JJ Radiat Oncol; 2015 Apr; 10():98. PubMed ID: 25896787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]